Finance

Lists
SLS:NASDAQ
Sellas Life Sciences Group Inc
$11.49
-0.35%
(-0.040) 1D
$11.55
+0.48% (+0.055)
After hours
Closed: Sep 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLS...
Open
$11.60
High
$11.78
Low
$11.06
Mkt. cap
2.32B
Avg. vol.
6.99M
Volume
14.61M
52-wk high
$15.88
52-wk low
$1.39
EPS
-$0.22
Beta
2.52
Shares outstanding
201.95M
No. of employees
13
Open
$11.60
High
$11.78
Low
$11.06
Mkt. cap
2.32B
Avg. vol.
6.99M
Volume
14.61M
52-wk high
$15.88
52-wk low
$1.39
EPS
-$0.22
Beta
2.52
Shares outstanding
201.95M
No. of employees
13
News stories
From web sources and news partners
About Sellas Life Sciences Group Inc
CEOAngelos M. Stergiou
Employees13
Founded2006
Headquarters-
SectorBiotechnology
Websitesellaslifesciences.com
Analyst ratings
Based on 2 analysts giving stock ratings to SLS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for SLS in the last 3 months.
Highest
Current $11.49
$30.00 (+161.10%)
Average
$27.50 (+139.34%)
Lowest
$25.00 (+117.58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$30.00
+161.1%
08/19/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
$25.00
+117.6%
07/06/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$25.00
+117.6%
07/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.22M
4.73M
5.13M
6.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.87M
2.42M
4.12M
3.36M
Operating expense
7.08M
7.16M
9.25M
9.63M
Total operating expenses
7.08M
7.16M
9.25M
9.63M
Operating income
-7.08M
-7.16M
-9.25M
-9.63M
Other non operating income
-
-
-
-
EBT including unusual items
-6.79M
-7.66M
-8.41M
-9.60M
EBT excluding unusual items
-6.79M
-6.56M
-8.41M
-8.60M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.79M
-7.66M
-8.41M
-9.60M
Net profit margin
-
-
-
-
Earnings per share
-0.06
-0.05
-0.05
-0.05
Interest and investment income
292.00K
597.00K
845.00K
1.02M
Interest expense
-
-
-
-
Net interest expenses
292.00K
597.00K
845.00K
1.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps